Quantitative evaluation of prion inactivation comparing steam sterilization and chemical sterilants: proposed method for test standardization

Journal of Hospital Infection

Volumn 64, Issue 2, 2006, Pages 143-148

  Vadrot, C ^a   Darbord, J C ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Disinfectants; Glutaraldehyde; Inactivation; Peracetic acid; Prion; Steam; Sterilization

Indexed keywords

GLUTARALDEHYDE; PERACETIC ACID; SODIUM HYDROXIDE; DISINFECTANT AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOCLAVE; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DEVICE; DISEASE TRANSMISSION; DISINFECTION; INCUBATION TIME; INFECTION RATE; INSTRUMENT STERILIZATION; METHODOLOGY; MOUSE; NONHUMAN; PRION; QUANTITATIVE ANALYSIS; STANDARDIZATION; TEMPERATURE; TIME; WATER VAPOR; ANIMAL; C57BL MOUSE; CROSS INFECTION; DISEASE MODEL; EQUIPMENT; EVALUATION; HEAT; HUMAN; INFECTION CONTROL; MICROBIOLOGY; PRION DISEASE; SCRAPIE; SURGICAL INSTRUMENT;

ANIMALS; CROSS INFECTION; DISEASE MODELS, ANIMAL; DISINFECTANTS; DISINFECTION; EQUIPMENT CONTAMINATION; HEAT; HUMANS; INFECTION CONTROL; MICE; MICE, INBRED C57BL; PRION DISEASES; SCRAPIE; SURGICAL INSTRUMENTS;

EID: 33750614430     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2006.06.007     Document Type: Article

References (25)

1. Peden A.H., Head M.W., Ritchie D.L., Bell J.E., and Ironside J.W. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 364 (2004) 527-529
2. Llewelyn C.A., Hewitt P.E., Knight R.S., et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 363 (2004) 417-421
3. Mead S., Prout K., and Collinge J. Questionnaire to reduce the risk of iatrogenic prion disease transmission. J Hosp Infect 60 (2005) 378-379
4. Head M.W., Ritchie D., Smith N., et al. Peripheral tissue involvement in sporadic, iatrogenic, and variant Creutzfeldt-Jakob disease: an immunohistochemical, quantitative, and biochemical study. Am J Pathol 164 (2004) 143-153
5. Dickinson A.G., and Taylor D.M. Resistance of scrapie agent to decontamination. N Engl J Med 299 (1978) 1413-1414
6. Brown P., Gibbs Jr. C.J., Amyx H.L., et al. Chemical disinfection of Creutzfeldt-Jakob disease virus. N Engl J Med 306 (1982) 1279-1282
7. Kimberlin R.H., Walker C.A., Millson G.C., et al. Disinfection studies with two strains of mouse-passaged scrapie agent. Guidelines for Creutzfeldt-Jakob and related agents. J Neurol Sci 59 (1983) 355-369
8. Brown P., Liberski P.P., Wolff A., and Gajdusek D.C. Resistance of scrapie infectivity to steam autoclaving after formaldehyde fixation and limited survival after ashing at 360 degrees C: practical and theoretical implications. J Infect Dis 161 (1990) 467-472
9. European Committee for Standardization (CEN). TC 216/prEN14885/WI216042. Application of European standards for chemical disinfectants and antiseptics. Part 4: categories of tests (2003), European Committee for Standardization, Brussels
10. Flechsig E., Hegyi I., Enari M., Schwarz P., Collinge J., and Weissmann C. Transmission of scrapie by steel-surface-bound prions. Mol Med 7 (2001) 679-684
11. Lemmer K., Mielke M., Pauli G., and Beekes M. Decontamination of surgical instruments from prion proteins: in vitro studies on the detachment, destabilization and degradation of PrPSc bound to steel surfaces. J Gen Virol 85 (2004) 3805-3816
12. Fichet G., Comoy E., Duval C., et al. Novel methods for disinfection of prion-contaminated medical devices. Lancet 364 (2004) 521-526
13. Yan Z.X., Stitz L., Heeg P., Pfaff E., and Roth K. Infectivity of prion protein bound to stainless steel wires: a model for testing decontamination procedures for transmissible spongiform encephalopathies. Infect Control Hosp Epidemiol 25 (2004) 280-283
14. Jackson G.S., McKintosh E., Flechsig E., et al. An enzyme-detergent method for effective prion decontamination of surgical steel. J Gen Virol 86 (2005) 869-878
15. Peretz D., Supattapone S., Giles K., et al. Inactivation of prions by acidic dodecyl sulfate. J Virol 80 (2006) 322-331
16. World Health Organization. Infection control guidelines for transmissible spongiform encephalopathies. Geneva: WHO/CDS/CSR/APH/2000; 1999.
17. Lazarini F., Deslys J.P., and Dormont D. Variations in prion protein and glial fibrillary acidic protein mRNAs in the brain of scrapie-infected newborn mouse. J Gen Virol 73 (1992) 1645-1648
18. Reed L.J., and Muench H. A simple method of estimating fifty percent endpoints. Am J Hyg 27 (1938) 493-497
19. Chartier V., Verjat D., Fargeot C., and Darbord J.C. Experimental results of detergent and pre-disinfection treatments before sterilization of medical devices. Zentr Steril 9 (2001) 100-107
20. Jacquemot C., Cuche C., Dormont D., and Lazarini F. High incidence of scrapie induced by repeated injections of subinfectious prion doses. J Virol 9 (2005) 8904-8908
21. Brown P., Rohwer R.G., and Gajdusek D.C. Newer data on the inactivation of scrapie virus or Creutzfeldt-Jakob disease virus in brain tissue. J Infect Dis 53 (1986) 1145-1148
22. Taylor D.M., Fraser H., McConnell I., et al. Decontamination studies with the agents of bovine spongiform encephalopathy and scrapie. Arch Virol 39 (1994) 313-326
23. Taylor D.M. Resistance of the ME7 scrapie agent to peracetic acid. Vet Microbiol 27 (1991) 19-24
24. Antloga K., Meszaros J., Malchesky P.S., and McDonnell G.E. Prion disease and medical devices. ASAIO J 46 (2000) S69-S72
25. Solassol J., Arlotto M., and Lehmann S. Detection of prion after decontamination procedures: comparative study of standard Western blot, filter retention and scrapie-cell assay. J Hosp Infect 57 (2004) 156-161